Literature DB >> 35005746

Comparison of the clinical efficacy of penicillin and ceftriaxone sodium in the treatment of neurosyphilis with psychiatric symptoms.

Shibin Wang1, Wenming Gu1, Yuping Cao2, Hangxiao Zheng1, Lei Zhang1, Xiaoyun Guo1, Wenzhong Chen1, Xingguang Luo3.   

Abstract

OBJECTIVE: To compare the clinical efficacy of penicillin and ceftriaxone sodium in the treatment of neurosyphilis with psychiatric symptoms.
METHODS: 50 neurosyphilis with mental symptoms patients were randomly divided into penicillin group (4 million units, Q4h) and ceftriaxone sodium group (1 g, Q12h). The total treatment time was 14 and 15 days respectively.The activity of daily living scale (ADL), brief psychiatric rating scale (BPRS) and mini-mental state examination (MMSE) were scored as the measurement of efficiency in living ability, mental symptoms and cognitive function. RESULT: There were no significant differences in ADL, MMSE and BPRS between the penicillin group and the ceftriaxone sodium treatment group (p > 0.05). After treatment, the score of BPRS and ADL decreased from baseline, while MMSE scores increased from baseline, having a main time effect (F=31.098,F=26.342,F= 79.916; p < 0.05).
CONCLUSION: Penicillin or ceftriaxone sodium are both effective in the aspect of mental symptoms, cognitive function and life ability among neurosyphilis with psychiatric symptoms patients.

Entities:  

Keywords:  ceftriaxone sodium; clinical efficacy; neurosyphilis; penicillin; psychiatric symptoms

Year:  2021        PMID: 35005746      PMCID: PMC8740858     

Source DB:  PubMed          Journal:  World J Psychiatry Ment Health Res


  18 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

Review 2.  Antibiotic use in sexually transmissible diseases.

Authors:  Ted Rosen; Travis Vandergriff; Mandy Harting
Journal:  Dermatol Clin       Date:  2009-01       Impact factor: 3.478

3.  2014 European guideline on the management of syphilis.

Authors:  M Janier; V Hegyi; N Dupin; M Unemo; G S Tiplica; M Potočnik; P French; R Patel
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-10-27       Impact factor: 6.166

4.  Syphilis: an ancient disease in a modern era.

Authors: 
Journal:  Lancet       Date:  2017-04-15       Impact factor: 79.321

5.  Neurocognitive and psychiatric changes as the initial presentation of neurosyphilis.

Authors:  Cecilia T Costiniuk; Paul A MacPherson
Journal:  CMAJ       Date:  2013-02-25       Impact factor: 8.262

6.  Ceftriaxone therapy for incubating and early syphilis.

Authors:  E W Hook; R E Roddy; H H Handsfield
Journal:  J Infect Dis       Date:  1988-10       Impact factor: 5.226

7.  Cognitive impairment in mild general paresis of the insane: AD-like pattern.

Authors:  Jianhong Wang; Qihao Guo; Pingyu Zhou; Jun Zhang; Qianhua Zhao; Zhen Hong
Journal:  Dement Geriatr Cogn Disord       Date:  2011-04-18       Impact factor: 2.959

8.  Cognitive change after treatment for neurosyphilis. Correlation with CSF laboratory measures.

Authors:  M C Roberts; R A Emsley
Journal:  Gen Hosp Psychiatry       Date:  1995-07       Impact factor: 3.238

9.  Neurosyphilis manifesting with rapidly progressive dementia: report of three cases.

Authors:  A Stefani; M Riello; F Rossini; S Mariotto; F Fenzi; G Gambina; G Zanusso; S Monaco
Journal:  Neurol Sci       Date:  2013-09-06       Impact factor: 3.307

10.  Antibiotic therapy for adults with neurosyphilis.

Authors:  Diana Buitrago-Garcia; Arturo J Martí-Carvajal; Adriana Jimenez; Lucieni O Conterno; Rodrigo Pardo
Journal:  Cochrane Database Syst Rev       Date:  2019-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.